Current Assets
Raw materials
Moderna Raw materials increased by 3.3% to $94M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 25.3%, from $75M to $94M. Over 5 years (FY 2020 to FY 2025), Raw materials shows an upward trend with a 19.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2020
Last reportedQ1 2026May 1, 2026
Parent metricInventories
Metric ID:
inv_raw_materialsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $378M | $605M | $870M | $1.07B | $1.4B | $1.54B | $575M | $475M | $507M | $149M | $163M | $215M | $199M | $171M | $63M | $75M | $83M | $85M | $91M | $94M |
| QoQ Change | — | +60.1% | +43.8% | +23.2% | +30.6% | +10.1% | -62.7% | -17.4% | +6.7% | -70.6% | +9.4% | +31.9% | -7.4% | -14.1% | -63.2% | +19.0% | +10.7% | +2.4% | +7.1% | +3.3% |
| YoY Change | — | — | — | — | +270.4% | +154.7% | -33.9% | -55.7% | -63.8% | -90.3% | -71.7% | -54.7% | -60.7% | +14.8% | -61.3% | -65.1% | -58.3% | -50.3% | +44.4% | +25.3% |
| % of Inventories | 58.8% | 62.7% | 60.4% | 55.2% | 72.9% | 74.2% | 63.2% | 54.3% | 70.1% | 70.6% | 95.9% | 148.3% | 123.6% | 263.1% | 42.0% | 56.0% | 65.4% | 73.9% | 79.8% | 80.3% |
| Share Change | — | +3.9pp | -2.3pp | -5.2pp | +17.7pp | +1.3pp | -11.0pp | -8.8pp | +15.8pp | +0.5pp | +25.3pp | +52.4pp | -24.7pp | +139.5pp | -221.1pp | +14.0pp | +9.4pp | +8.6pp | +5.9pp | +0.5pp |
Range$63M – $1.54B
CAGR-25.4%
Avg YoY Growth-9.8%
Median YoY Growth-55.2%
Current Streak5 quarters growth
Raw materials at Other Companies
Frequently Asked Questions
- What is Moderna's raw materials?
- Moderna (MRNA) reported raw materials of $94M in Q1 2026.
- How has Moderna's raw materials changed year-over-year?
- Moderna's raw materials increased by 25.3% year-over-year, from $75M to $94M.
- What is the long-term trend for Moderna's raw materials?
- Over 5 years (2020 to 2025), Moderna's raw materials has grown at a 19.7% compound annual growth rate (CAGR), from $37M to $91M.